指南与共识中毒与环境急症消化、代谢与肾脏急症

美国和加拿大院外对乙酰氨基酚暴露评估与分诊共识指南

Out-of-hospital assessment and triage of paracetamol (acetaminophen) exposure in the United States and Canada: a consensus guideline.
指南 / 共识 · Clin Toxicol (Phila) · 2025-03-06
一句话结论共识指南建议:摄入史准确时,按对乙酰氨基酚摄入量阈值(≥200 mg/kg或10 g取较小值/24 h等)决定是否转诊急诊。

该共识指南由四个临床毒理学学会选出的21名专家采用改良德尔菲法制定,系统收集美加多数中毒中心指南并系统检索文献。指南涵盖急性摄入(首次摄入后24 h内就诊)和反复超治疗剂量摄入(暴露持续24 h或以上),强调获取准确摄入史,并依据摄入剂量和模式决定是否转诊急诊。推荐转诊急诊的摄入量阈值为:24 h内≥200 mg/kg或10 g(取较小值);48 h内≥150 mg/kg/24 h或6 g/天(取较小值);超过48 h≥100 mg/kg/24 h或4 g/天(取较小值)。

要点

  • 急性摄入定义为首次摄入后24 h内就诊,无论摄入模式;反复超治疗剂量摄入定义为暴露持续24 h或以上。
  • 摄入史准确时,依据剂量和摄入模式决定是否转诊:24 h内≥200 mg/kg或10 g(取较小值)应转诊急诊。
  • 48 h内摄入≥150 mg/kg/24 h或6 g/天(取较小值)应转诊急诊。
  • 超过48 h摄入≥100 mg/kg/24 h或4 g/天(取较小值)应转诊急诊。
  • 指南强调获取准确摄入史的重要性;尽管有乙酰半胱氨酸,漏诊和治疗延迟仍可导致致命性肝衰竭。

适用人群与场景

  • 美国和加拿大院外对乙酰氨基酚暴露患者的评估与分诊。
  • 涵盖急性摄入和反复超治疗剂量摄入模式。

诊断标准与关键阈值

  • 急性摄入:任何摄入模式,首次摄入后24 h内就诊。
  • 反复超治疗剂量摄入:暴露持续24 h或以上。
  • 转诊急诊阈值(摄入史准确时):24 h内摄入≥200 mg/kg或10 g(取较小值)。
  • 转诊急诊阈值:48 h内摄入≥150 mg/kg/24 h或6 g/天(取较小值)。
  • 转诊急诊阈值:超过48 h摄入≥100 mg/kg/24 h或4 g/天(取较小值)。

处置流程与药物剂量

  • 强调获取准确摄入史;摄入史确定准确后,依据剂量和摄入模式决定治疗转诊。
  • 摄入量达到上述任一阈值时,推荐将患者转诊至急诊科。

红旗征与不能漏的情况

  • 漏诊需要乙酰半胱氨酸治疗的患者与显著发病率和死亡率相关。
  • 尽管有乙酰半胱氨酸可用,部分患者因漏诊和治疗延迟仍发生致命性肝衰竭。

研究设计与关键结果

  • 采用改良德尔菲共识方法建立院外对乙酰氨基酚过量评估决策框架。
  • 由四个临床毒理学学会(America's Poison Centers®、美国临床毒理学学会、美国医学毒理学学会、加拿大中毒中心与临床毒理学协会)选出21名专家组成专家组。
  • 收集了美国和加拿大多数中毒中心的指南,并系统收集和复习医学文献。
  • 专家组制定了涵盖急性摄入和反复超治疗剂量摄入模式的院外管理指南。

证据类型、等级与局限

  • 证据类型:共识指南(改良德尔菲法)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 院外评估对乙酰氨基酚暴露时,应首先获取准确摄入史,再依据摄入剂量和模式对照阈值决定是否转诊急诊。
  • 需标准化院外评估与分诊,以减少漏诊需要乙酰半胱氨酸治疗的患者,避免治疗延迟。

指南或共识出处

  • 指南名称:Out-of-hospital assessment and triage of paracetamol (acetaminophen) exposure in the United States and Canada: a consensus guideline。
  • 发布机构:America's Poison Centers®、美国临床毒理学学会、美国医学毒理学学会、加拿大中毒中心与临床毒理学协会。
  • 期刊:Clin Toxicol (Phila)。

提炼说明

  • 本条依据论文摘要整理;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Consensus guidelines for out-of-hospital assessment and triage of paracetamol (acetaminophen) exposure were published in 2006. Changes in the healthcare system, paracetamol ingestion trends, and availability of paracetamol-containing products necessitate an update to these guidelines. Updated guidelines were created for out-of-hospital management of paracetamol exposure in the United States and Canada.

METHODS: A modified Delphi consensus methodology was used to create a decision framework to evaluate clinical aspects of care related to paracetamol overdose in the out-of-hospital setting. Twenty-one panelists were selected by four clinical toxicology societies (America's Poison Centers®, American Academy of Clinical Toxicology, American College of Medical Toxicology, and Canadian Association for Poison Centres and Clinical Toxicology) to participate as panelists. Guidelines were collected from most poison centers in the United States and Canada, and systematic collection and review of medical literature was conducted.

RESULTS: The panel developed a guideline for out-of-hospital management of paracetamol exposure that encompasses acute and repeated supratherapeutic ingestion patterns. Acute ingestion is defined as any ingestion presenting within 24 h of initial ingestion, regardless of ingestion pattern. Repeated supratherapeutic ingestion is defined as an exposure that occurs over a period of 24 h or more. This guideline emphasizes the importance of obtaining accurate history. When ingestion history is determined as accurate, dosage and ingestion pattern are used to decide treatment referral. It is recommended that patients be referred to the emergency department if their ingestion amount is: (1) ≥200 mg/kg or 10 g (whichever is less) within 24 h; (2) ≥150 mg/kg/24 h or 6 g/day (whichever is less) within 48 h; (3) ≥100 mg/kg/24 h or 4 g/day (whichever is less) for more than 48 h.

DISCUSSION: The need for standardizing the out-of-hospital assessment and triage of paracetamol exposure is pressing. Despite the availability of acetylcysteine, some patients develop fatal liver failure due to missed diagnoses and delays in treatment. Failure to recognize cases requiring acetylcysteine is associated with significant morbidity and mortality.

CONCLUSION: This consensus statement provides evidence-based guidance for out-of-hospital management of paracetamol ingestion to standardize healthcare facility referral criteria for paracetamol exposed patients.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Fox EJ, Dalton AM, Mullins ME, et al. Out-of-hospital assessment and triage of paracetamol (acetaminophen) exposure in the United States and Canada: a consensus guideline. Clin Toxicol (Phila). 2025. PMID: 40047505. doi:10.1080/15563650.2025.2471915

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。